Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name list3,4-Dihydro Naratriptan (Naratriptan Impurity B)

3,4-Dihydro Naratriptan (Naratriptan Impurity B)

3,4-Dihydro Naratriptan (Naratriptan Impurity B) Structural

What is 3,4-Dihydro Naratriptan (Naratriptan Impurity B)?

The Uses of 3,4-Dihydro Naratriptan (Naratriptan Impurity B)

Naratriptan related compound B. Naratriptan impurity B.

What are the applications of Application

3,4-Dihydro Naratriptan (Naratriptan Impurity B) is a Naratriptan related compound B and Naratriptan impurity B

Biological Activity

pki: 8.9 of naratriptan for human 5-ht1b3,4-dihydro naratriptan is a selective serotonin 5-ht1b agonist.5-ht1b receptors are widely distributed throughout the cns with the highest concentrations found in the basal ganglia, frontal cortex, striatum, and the hippocampus. the function of the 5-ht1b receptor differs depending upon its location.

in vitro

3,4-dihydro naratriptan is an impurity formed during the preparation of naratriptan. naratriptan had high affinity for human recombinant 5ht1b and 5ht1d receptors and could cause contractions of dog isolated basilar and middle cerebral artery. naratriptan also caused small contractions of human isolated coronary arteries [1].

in vivo

in anaesthetized dogs, naratriptan caused selective vasoconstriction of the carotid arterial bed and, in anaesthetized rats, naratriptan selectively inhibited neurogenic plasma protein extravasation in the dura. in various antinociceptive tests, naratriptan had no effect even at high doses. in conscious rats and dogs, naratriptan had high oral bioavailability [1].

References

[1] connor he, feniuk w, beattie dt, north pc, oxford aw, saynor da, humphrey pp. naratriptan: biological profile in animal models relevant to migraine. cephalalgia. 1997 may;17(3):145-52.
[2] dulli da. naratriptan: an alternative for migraine. ann pharmacother. 1999 jun;33(6):704-11.

Properties of 3,4-Dihydro Naratriptan (Naratriptan Impurity B)

Melting point: >187°C (dec.)
storage temp.  Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility  DMSO (Slightly), Methanol (Slightly)
form  Solid
color  White to Off-White
Stability: Hygroscopic

Safety information for 3,4-Dihydro Naratriptan (Naratriptan Impurity B)

Computed Descriptors for 3,4-Dihydro Naratriptan (Naratriptan Impurity B)

You may like

  • 121679-20-7 Naratriptan Impurity B 98%
    121679-20-7 Naratriptan Impurity B 98%
    121679-20-7
    View Details
  • (R)-(3-(3-fluoro-4- thiomorpholinophenyl)-2- oxooxazolidin-4-yl) methyl methanesulfonate
    (R)-(3-(3-fluoro-4- thiomorpholinophenyl)-2- oxooxazolidin-4-yl) methyl methanesulfonate
    2416850-45-6
    View Details
  • methyl 3-fluoro-4- thiomorpholino phenylcarbamate
    methyl 3-fluoro-4- thiomorpholino phenylcarbamate
    2760359-22-4
    View Details
  • Fuel shell 98%
    Fuel shell 98%
    View Details
  • 4,6-dichloro-2-propylthiopyrimidine-5-amine 145783-15-9 98%
    4,6-dichloro-2-propylthiopyrimidine-5-amine 145783-15-9 98%
    145783-15-9
    View Details
  • 151767-02-1 Montelukast Sodium IP/USP 98%
    151767-02-1 Montelukast Sodium IP/USP 98%
    151767-02-1
    View Details
  • Valacyclovir Hydrochloride IH 98%
    Valacyclovir Hydrochloride IH 98%
    124832-27-5
    View Details
  • 2-[2-[3(S)-3[2-(7-chloro-2-quinolinyl) ethenyl] phenyl-3- hydroxyl propyl] phenyl]-2-propanol 98%
    2-[2-[3(S)-3[2-(7-chloro-2-quinolinyl) ethenyl] phenyl-3- hydroxyl propyl] phenyl]-2-propanol 98%
    142569-70-8
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.